Letter to the Editors: Concerning BLong-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al Response

被引：1
|
作者：
Lee, Youngmok [1 ]
Chou, Janice Y. [2 ]
Weinstein, David A. [1 ]
机构：
[1] Univ Connecticut, Hlth Ctr, Farmington, CT 06030 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Differentiat, Bethesda, MD USA
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2018年 / 41卷 / 06期
关键词：
PREVENTION; LIVER;
D O I：
10.1007/s10545-018-0249-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：915 / 915
页数：1
相关论文
共 46 条
  • [1] Letter to the Editors: Concerning "Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al.
    Brooks, Elizabeth D.
    Kishnani, Priya S.
    Koeberl, Dwight D.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 913 - 914
  • [2] Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia
    Lee, Young Mok
    Conlon, Thomas J.
    Specht, Andrew
    Coleman, Kirsten E.
    Brown, Laurie M.
    Estrella, Ana M.
    Dambska, Monika
    Dahlberg, Kathryn R.
    Weinstein, David A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 977 - 984
  • [3] Efficacy of gene therapy in canine glycogen storage disease type IA.
    Pinto, C. R.
    Brown, T. R.
    Vaughn, V.
    Bird, A.
    Sun, B. D.
    Koeberl, D. D.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (03) : 606 - 606
  • [4] HIGHLY EFFICACIOUS GENE THERAPY IN THE CANINE MODEL FOR GLYCOGEN STORAGE DISEASE TYPE IA
    Luo, Xiaoyan
    Demaster, Amanda
    Crane, Bayley
    Pinto, C. R.
    Brown, T. T.
    Kozink, D. M.
    Bird, A.
    Kishnani, P. S.
    Koeberl, D. D.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 221 - 222
  • [5] Bezafibrate Enhances AAV Gene Therapy in Glycogen Storage Disease Type Ia
    Kang, Hye Ri
    Waskowicz, Lauren
    Koeberl, Dwight D.
    MOLECULAR THERAPY, 2018, 26 (05) : 447 - 447
  • [6] Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy
    Brooks, Elizabeth D.
    Landau, Dustin J.
    Everitt, Jeffrey I.
    Brown, Talmage T.
    Grady, Kylie M.
    Waskowicz, Lauren
    Bass, Cameron R.
    D'Angelo, John
    Asfaw, Yohannes G.
    Williams, Kyha
    Kishnani, Priya S.
    Koeberl, Dwight D.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 965 - 976
  • [7] Gene therapy with adeno-associated virus (AAV) vectors in canine glycogen storage disease, type Ia.
    Beaty, RM
    Jackson, M
    Kishnani, PS
    Faulkner, E
    VanCamp, S
    Brown, T
    Boney, A
    Chen, YT
    Koeberl, DD
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 432 - 432
  • [8] BEZAFIBRATE TREATMENT ENHANCES EFFICIENCY OF AAV GENE THERAPY ON GLYCOGEN STORAGE DISEASE TYPE IA
    Kang, Hye-Ri
    Waskowicz, Lauren
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (03) : 201 - 201
  • [9] Long term treatment of glycogen storage disease type IA: Clinical summary of a canine model
    Drake, Elizabeth J.
    Demaster, Amanda
    Luo, Xiaoyan
    Curtis, Sarah
    Williams, Kyha D.
    Landau, Dustin J.
    Kozink, Daniel M.
    Bird, Andrew
    Crane, Bayley
    Sun, Francis
    Pinto, Carlos R.
    Brown, Talmage T.
    Kemper, Alex R.
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (03) : 314 - 314
  • [10] Development of adeno-associated virus (AAV) vectors for gene therapy in the mouse model for glycogen storage disease type Ia (GSD-Ia)
    Koeberl, DD
    Sun, BD
    Franco, L
    Bird, A
    Faulkner, E
    Chen, YT
    MOLECULAR THERAPY, 2004, 9 : S404 - S404
12345